22.07.2011 • NewsSyngentaH1 2011Mike Mack

Syngenta H1 Profit Up

Syngenta reported a 14% rise in its first-half net income attributable to the company's shareholders to $1.43 billion from $1.25 billion last year. Excluding restructuring and impairment, quarterly earnings per share were $15.60, higher than $13.95 in the year earlier period.

The company reported first-half sales of $7.7 billion, up 14% from $6.74 billion in the comparable period a year ago. Sales at constant exchange rates or CER increased by 12%.

Mike Mack, chief executive, noted, "We expect to generate 2011 full year free cash flow in excess of $1 billion.

In addition, the outlook for pricing for the rest of the year is positive and we expect stable pricing for the full year. For the 2012 season, we are currently raising prices across the business with the aim of achieving an overall increase in the mid single digits."

 

Company

Syngenta International AG


Basel
Switzerland

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.